Comparative statistics by cancer site (ICD-10)

ICD-10: Comparative statistics by registry

Table 2b: Number and proportion of cases by vital status and median follow-up (in months) by site


Click on country-registry for comparison

FlagCountry-registryRegistration periodTotal includedDeadAliveComplete FUMedian FU (in months)
No.%No.%No.%
China - Hong Kong SAR1996-2001121050741.970358.11210100.041.6
China - Qidong1992-2000472655.32144.747100.010.7
China - Tianjin1991-1999104073.20.110.001.00.1
India - Bhopal1991-1995605998.311.760100.018.8
Singapore1993-199731117455.913744.1311100.045.9
Republic of Korea - Busan1996-200147523449.324150.7475100.037.6
Republic of Korea - Incheon1997-20012229141.013159.0222100.023.9
Republic of Korea - Seoul1993-199779132040.547159.5791100.058.5



Other tables available:

- Table 1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b: Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6: Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9: Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period